XML 11 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 1,420 $ 95,938
Inventories 108,796 113,688
Prepayment, deposits and other receivables 213,007 132,747
Total current assets 323,223 342,373
Non-current Assets    
Right-of-use assets, net 34,954
Total non-current assets 34,954
TOTAL ASSETS 323,223 377,327
Current liabilities    
Trade payables 2,325 12,597
Other payables and accrued liabilities 9,532 32,242
Deferred revenue 165 14,782
Amount due to a director 481,100 501,890
Lease liability – current portion 34,954
Total current liabilities 493,122 596,465
TOTAL LIABILITIES 493,122 596,465
STOCKHOLDERS’ DEFICIT    
Common stock, $0.0001 par value; 800,000,000 shares authorized; 101,400,000 shares of common stock issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 10,140 10,140
Additional paid-in capital 148,860 148,860
Accumulated other comprehensive income 5,477 1,860
Accumulated deficit (334,376) (379,998)
TOTAL STOCKHOLDERS’ DEFICIT (169,899) (219,138)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $ 323,223 $ 377,327